Investors

Analyst Coverage

Cardiol Therapeutics Inc. is followed by the analysts listed below. Please note that any opinion, estimates or forecasts regarding Cardiol’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions by Cardiol or its management. Cardiol does not by its reference below or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Analyst Firm Email
Charles C. Duncan, PhD Cantor Fitzgerald charles.duncan@cantor.com
Douglas W. Loe, PhD, MBA Leede Jones Gable dloe@leedejonesgable.com
Edward Nash, MBA, MPH Canaccord Genuity enash@cgf.com